Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment

CHEN-HUA LIUChen C.-Y.Su W.-W.Tseng K.-C.Lo C.-C.CHUN-JEN LIUChen J.-J.Peng C.-Y.Shih Y.-L.Yang S.-S.Huang C.-S.Huang K.-J.Chang C.-Y.Tsai M.-C.Kao W.-Y.YU-JEN FANGChen P.-Y.Su P.-Y.Tseng C.-W.Huang J.-J.Lee P.-L.Lai H.-C.Hsieh T.-Y.Chang C.-H.Huang Y.-J.Lee F.-J.Chang C.-C.JIA-HORNG KAO2021-09-042021-09-0420200017-5749https://www.scopus.com/inward/record.uri?eid=2-s2.0-85099016332&doi=10.1136%2fgutjnl-2020-323569&partnerID=40&md5=b28befe764f894bb06460ef48600e0f4https://scholars.lib.ntu.edu.tw/handle/123456789/581774[SDGs]SDG3Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairmentjournal article10.1136/gutjnl-2020-3235692-s2.0-85099016332